PT-141 (bremelanotide): a research overview

PT-141, also called bremelanotide, is a peptide studied in melanocortin-system research. This overview covers its structure and handling, with no therapeutic or dosing claims.

What it is

PT-141 is a cyclic melanocortin-receptor agonist, structurally related to Melanotan-2 within the melanocortin family of research peptides. It is supplied lyophilised.

Why it is studied

PT-141 appears in preclinical and in-vitro literature on melanocortin-receptor signalling. The findings belong to those studies; this page makes no claim about human effects.

Handling notes

• Supplied lyophilised; reconstitute gently.
• Keep the dry solid sealed, cold and dark.
• Refrigerate after reconstitution and aliquot for repeated use.

For in-vitro research use only. Not for human or veterinary use.